Abstract
Radiolabeled monoclonal antibodies have been shown to react preferentially to neoplastic cells and offer new approaches for targeted cancer treatment [1]. Monoclonal antibody technology [2] enables an antibody-producing lymphocyte to be fused with a cultured myeloma cell, thus producing a hybridoma that secretes a specific monoclonal antibody. It is now possible to manufacture large quantities of immunoglobulins with unique specificity. Monoclonal antibodies have been raised against tumor-associated antigens found in many types of cancer such as breast, lung, colonic, ovarian and bone cancer, as well as glioma, melanoma etc. Great effort has been directed towards the use of monoclonal antibodies to target potent cytotoxic or biologically active agents. Radiolabeled monoclonal antibodies have been utilised in patients for tumour localisation by external body scintigraphy, and encouraging clinical results have been reported by many workers [3–6]. Other potential uses of monoclonal antibodies include the delivery of chemotherapy [7], toxins [8] or radionuclides [9–13] to specifically destroy tumour cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Epenetos AA, Britton KE, Mather S, Shepherd J, Geanovska M, Taylor-Papadimitriou J, Nimmon CC, Durbin H, Hawkins LR, Malpas JS, Bodmer WF (1982) Targetting of Iodine 123-labelled tumour associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet 2: 999–1005
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497
Mach J-P, Buchegger F, Forni M, Ritschard J, Berche C, Lumbroso JD, Schreyer M, Girardet C, Accola R, Carrel S (1981) Use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol Today 2: 239–249
Farrands PA, Perkins AC, Pimm MV, Hardy JD, Embleton MJ, Baldwin RW, Hardcastle JD (1982) Radioimmunodetection of human colorectal cancer by an antitumour monoclonal antibody. Lancet 2: 397–400
Larson SM, Brown JP, Wright PW, Carrasquillo JA, Hellstrom I, Hellstrom KE (1983) Imag¬ing of melanomas with 1131-labelled monoclonal antibodies. J Nucl Med 23: 123–129
Buraggi GL, Callegaro L, Mariani G, Turrin A, Caseinelli N, Attili A, Bombardiert E, Terno G, Plassio G, Dovis M (1985) Imaging with 131I-labelled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: Efficacy of whole immunoglobulin and its F(ab’)2 fragments. Cancer Res 45: 3378–3387
Baldwin RW, Pimm V (1983) Antitumour monoclonal antibodies for radioimmunodetection of tumours and drug targetting. Cancer Metastasis Rev 2: 89–106
Thorpe RE, Ross WC (1982) The preparation and cytotoxic properties of antibody-toxin conjugates. Immunol Rev 62: 119
Order SE, Klein JL, Ettinger D, Alderson P, Siegelman S, Leichner P (1980) Use of isotopic immunoglobulin in therapy. Cancer Res 40: 3001
Epenetos AA, Courtenay-Luck N, Hainan KE, Hooker G, Hughes JMB, Krauz T, Lambert J, Lavender JP, MacGregor WG, McKenzie CG, Munro A, Myers MJ, Orr JS, Pearse EE, Snook D, Webb B, Burcell J, Durbin H, Kemshead J, Taylor-Papadimitriou J (1984) Antibody guided irradiation of malignant lesions. Lancet 30: 1441–1443
Carrasquilo JA, Krohn KA, Beaumier P, McGuffin RW, Brown JP, Hellstrom E, Hellstrom I, Larson SM (1984) Diagnosis of and therapy for solid tumour with radiolabeled antibodies and immune fragments. Cancer Treat Rep 68: 371–378
Epenetos AA, Courtenay-Luck N, Pickering D, Hooker G, Durbin H, Lavender JP, McKenzie CG (1985) Antibody-guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br Med J 290: 1463–1466
Epenetos AA, Munro AJ, Stewart S, Rampling R, Lambert HE, McKenzie CG, Soutter P, Rahemtulla A, Hooker G, Sivolapenko GB, Snook D, Courtenay-Luck N, Dhokia B, Krauz T, Taylor-Papadimitriou J, Durbin H, Bodmer WF (1987) Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies. J Clin Oncol 5: 1890–1899
Kalofonos HP, Epenetos AA (1987) Antibody-guided diagnosis and therapy of patients with breast cancer. In: Ceriani RL (ed) Immunological approaches to the diagnosis and therapy of breast cancer. Plenum, New York, pp 245–257
Wilson CB, Epenetos AA (1987) Use of monoclonal antibodies for diagnosis and treatment of liver tumours. Bailliere’s Clinical Gastroenterology 1 (1): 115–130
Arklie J, Taylor-Papadimitriou J, Bodmer WF, Egan M, Millis R (1981) Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer 28: 23–29
Burcell J, Durbin H, Taylor-Papadimitriou J (1983) Complexity of expression on antigenic determinants recognised by monoclonal antibodies HMFG1 and HMFG2 in normal and malignant tissue. J Immunol 131: 508–513
Epenetos AA, Nimmon CC, Arklie J, Elliot AT, Hawkins LA, Knowles RW, Britton KE, Bodmere WF (1982) Radioimmuno-diagnosis of human cancer in an animal model using labelled tumour associated monoclonal antibodies. Br J Cancer 46: 1–8
Travers P, Bodmer WF (1984) Preparation and characterization of monoclonal antibodies against placental alkaline phosphatase and other human trophoblast-associated determinants. Int J Cancer 33: 633–641
Waterfield MD, Mayes ELV, Stroonbard P, Bennet PL, Young G, Goodfellow PN, Banting GS, Ozone B (1982) A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem 20: 148–161
Bosslet K, Lüben G, Schwarz A, Hundt E, Harthus HP, Seiler TR, Muhrer C, Klöppel G, Kayser K, Sedlacek HH (1985) Immunohistochemical localisation and molecular characteris-tics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen ( CEA ). Int J Cancer 36: 75
Leichner PK, Klein JL, Garrison JB, Jenkins RE, Nickoloff EL (1981) Dosimetry of 1131-labelled anti-ferritin in hepatoma: a model for radio-immunoglobulin dosimetry. Int J Rad On Biol Phys 7: 323–333
Larson SM, Carrasquillo JA, McGuffin RW, Kohn KA, Ferens JM, Hill LD, Beaumier PL, Reynolds JC, Hellstrom KE, Hellstrom I (1985) Use of 131I-labelled murine Fab against a high molecular weight antigen of human melanoma. Preliminary experience. Radiology 155: 487–492
Fraker PJ, Speck JC (1978) Protein and cell membrane iodination with a sparingly soluble chloramine 1,3,4,6,tetrachloro-5,6-diphenyl-glycoril. Biochem Biophys Res Commun 80: 849–854
Hnatowich DJ, Layne WW, Childs RL (1983) Radioactive labeling of antibody: a simple and efficient method. Science 220: 613–615
Hnatowich DJ, Virzi F, Doherty PW (1985) DTPA-coupled antibodies labelled with yttrium 90. J Nucl Med 5: 503–509
Snyder WS, Ford MR, Warner GG (1978) Estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous phantom. Medical International Radiation Dose (MIRD) pamphlet 5. Society of Nuclear Medicine, New York, pp 55–67
Myers MJ, Lavender JP, de Oliveira JB (1981) A simplified method of quantitating organ uptake using a gamma camera. Br J Radiol 54: 1062–1067
Myers MJ, Hooker GR, Epenetos AA (1986) Dosimetry of radiolabelled monoclonal antibodies used for therapy. In: Schlafke-Stelson AT, Watson EE (eds) Fourth International Radio-pharmaceutical Dosimetry Symposium, 5–8 Nov 1985. Oak Ridge Associated Universities, Oak Ridge, Tennessee, pp 409–420
Ward BG, Mather SJ, Shepherd JH (1986) Prospects for antibody targetted radiotherapy of cancer. Lancet 2: 580–581
Malamitsi J, Skarlos D, Fotiou S, Valvaligiou A, Papakostas P, Aravantinos G, Taylor-Papadimitriou J, Epenetos AA, Koutoulidis K (in press). Pharmacokinetics and diagnostic contribution of I 131-labelled HMFG2 monoclonal antibody in pleural and peritoneal metastases from breast and ovarian carcinomas: Advantages of intracavitary administration. J Nucl Med (in press)
Stoscheck CM, King LE (1986) Role of epidermal growth factor in carcinogenesis. Cancer Res 4: 1030–1037
Courtenay-Luck N, Epenetos AA, Moore R, Larche M, Pectasides D, Dhokia B, Ritter MA (1986) Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res 46: 6489–6493
Epenetos AA, Snook D, Durbin H, Johnson PM, Taylor-Papadimitriou J (1986) Limitations of radiolabelled monoclonal antibodies for the localisation of human neoplasms. Cancer Res 46: 3181–3191
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Kalofonos, H., Epenetos, A.A. (1989). Radioimmunotherapy with Iodine 131-Labelled Antibodies in Ovarian, Colonic and Brain Tumours. In: Beger, H.G., Büchler, M., Reisfeld, R.A., Schulz, G. (eds) Cancer Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73721-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-73721-3_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73723-7
Online ISBN: 978-3-642-73721-3
eBook Packages: Springer Book Archive